Adjuvant Glucagon-Like Peptide-1 Receptor Agonist Therapy Post-Bariatric Surgery: An Exploratory Single-Institution Analysis
Journal of Surgical Research · 2026
DOI: 10.1016/j.jss.2026.08.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Research, 2026. Verfasst von Arthur A Cross-Najafi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Minimally Invasive and Bariatric Surgery, Department of Surgery, Rush University Medical Center, Chicago, Illinois. Electronic address: A…. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Gastric Bypass, Obesity, Morbid, Bariatric Surgery. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Suboptimal clinical response can occur after bariatric surgery. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are becoming increasingly available for managing obesity and may augment weight loss after bariatric surgery. This exploratory study aimed to evaluate the association between adjuvant GLP-1RA use and post-bariatric surgery weight loss outcomes. METHODS: A single-institution retrospective cohort of adults who underwent sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) between July 2022 and June 2024 was identified. Patients initiated on GLP-1RA therapy (semaglutide or tirzepatide) within one year postoperatively (adjuvant GLP-1RA) were compared to those without GLP-1RA therapy (GLP-naive). Propensity-score matched outcomes, including total weight loss percentage (TWL%) and excess weight loss percentage, were compared at 2 wk and 3, 6, and 12 mo postoperatively. RESULTS: A total of 808 patients were identified. Adjuvant GLP-1RA and GLP-naive groups consisted of 22 and 385 (SG) and 7 and 394 (RYGB) patients, respectively. The mean time-to-initiation of GLP-1RA therapy was 7.8 ± 3.0 mo (SG) and 7.9 ± 2.3 mo (RYGB) postoperatively. No statistically significant difference in weight loss outcomes was observed between the adjuvant GLP-1RA or GLP-naive groups in either procedural cohort at any postoperative time point after propensity score matching on baseline characteristics and early postoperative weight loss (P ≥ 0.07). Within the SG procedural cohort, TWL% was numerically higher in the adjuvant GLP-1RA group but did not reach statistical significance (22.6% versus 18.3%, P = 0.07). CONCLUSIONS: Adjuvant GLP-1RA therapy was not associated with significantly improved weight loss outcomes after bariatric surgery, though a trend toward increased TWL% with adjuvant GLP-1RA therapy was observed for patients who underwent SG. Larger, prospective studies evaluating earlier initiation and longer duration of post-bariatric GLP-1RA therapy are needed to further characterize the potential benefit of this intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Minimally Invasive and Bariatric Surgery, Department of Surgery, Rush University Medical Center, Chicago, Illinois. Electronic address: Arthur_CrossNajafi@rush.edu.
- Division of Minimally Invasive and Bariatric Surgery, Department of Surgery, Rush University Medical Center, Chicago, Illinois.
Zitieren
APA
Cross-Najafi, A. A., Benavidez, M. C., No, J. J., Ngo, K. C., Redpath, S., Nin, D. Z., Schimpke, S. W., Myers, J. A., Omotosho, P., Torquati, A., & Skertich, N. J. (2026). Adjuvant Glucagon-Like Peptide-1 Receptor Agonist Therapy Post-Bariatric Surgery: An Exploratory Single-Institution Analysis. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2026.08.047
Vancouver
Cross-Najafi AA, Benavidez MC, No JJ, Ngo KC, Redpath S, Nin DZ, et al. Adjuvant Glucagon-Like Peptide-1 Receptor Agonist Therapy Post-Bariatric Surgery: An Exploratory Single-Institution Analysis. Journal of Surgical Research. 2026. doi:10.1016/j.jss.2026.08.047
BibTeX
@article{CrossNajafi2026,
author = {Cross-Najafi, Arthur A and Benavidez, Maria C and No, Jennifer J and Ngo, Kim C and Redpath, Sophia and Nin, Darren Z and Schimpke, Scott W and Myers, Jonathan A and Omotosho, Philip and Torquati, Alfonso and Skertich, Nicholas J},
title = {Adjuvant Glucagon-Like Peptide-1 Receptor Agonist Therapy Post-Bariatric Surgery: An Exploratory Single-Institution Analysis},
journal = {Journal of Surgical Research},
year = {2026},
doi = {10.1016/j.jss.2026.08.047}
}
EUVIMED